Viewing nowInnoen Losartan Tablets 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

MFDS item code 200500111 · Notified 2005.02.01
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension and is especially effective in treating kidney disease in patients with type 2 diabetes. Therefore, it helps prevent complications associated with hypertension.
1. Hypertension Adults The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive drug (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered in combination with insulin or commonly used antidiabetic drugs (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient groups Older adults No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. Patients with reduced effective intravascular volume An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic treatment) (see Precautions for Use). Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 50mg once daily. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; depending on the patient's blood pressure response, the dose may be increased to a maximum of 100 mg once daily. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This drug can cause serious harm to the fetus, particularly during the second and third trimesters of pregnancy, so women who are pregnant or may become pregnant should not take it. It poses risks such as decreased lung formation, skeletal deformities, and reduced kidney function. If pregnancy is confirmed, it should be discontinued immediately. This drug should not be administered to patients with severely impaired liver function or hereditary angioedema. Additionally, patients with lactose intolerance should not take this medication. Caution is advised in elderly patients, those with impaired kidney function, and those with elevated serum potassium levels; regular checks are necessary as blood pressure may drop too low or kidney function may deteriorate. While taking this drug, side effects such as muscle pain, dizziness, headache, dyspepsia, and cough may occur. Rarely, serious side effects such as angioedema, liver dysfunction, and rhabdomyolysis may arise, and any unusual symptoms should be reported to healthcare professionals immediately. Taking this medication with other antihypertensives, potassium-sparing diuretics, or potassium supplements may dangerously elevate potassium levels, requiring consultation with a physician. Caution is warranted when used with non-steroidal anti-inflammatory drugs as it may reduce efficacy or affect kidney function. Grapefruit juice may decrease the efficacy of this medication, so it is advisable to avoid grapefruit juice during treatment. It is preferable for pregnant and nursing women not to use this medication, and nursing should be discontinued if using this drug. Children, especially those under the age of 6 or those with significantly impaired kidney function, should not use this medication. In cases of overdose, hypotension and tachycardia may occur, and symptomatic treatment should be sought immediately. This medication should be kept out of the reach of children and should not be transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container, protected from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medication's efficacy and prevent deterioration.
White oval film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.